Safety and Performance Study of the Electroencephalographic Recording Device and Sound Emissions
NCT ID: NCT04875442
Last Updated: 2023-10-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2023-10-30
2026-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Electroencephalographic Study of the Mechanisms of Inhibition of Emotional Memories in Young Healthy Subjects
NCT06891612
Decoding and Selective Modulation of Human Memory During Awake/Sleep Cycles
NCT05452122
In-depth Investigation of Brain Network Interactions
NCT04748146
Continuous Measurement of Glymphatic Activity in the Human Brain During Sleep-Wake States
NCT06060054
Links Between Cognitive Deficits During Normal or Pathological Aging and Slow Waves Measured in EEG
NCT06501495
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Each patient spends 3 polysomnography nights at hospital: 1 night of habituation without Memowave device and next 2 nights with Memovave.
The device emits sounds to increase slow brain waves but Memowave emits sounds during only one of the two nights of test (night placebo vs night "verum"). The attribution of the night is randomized.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
The night during which the device emits sounds is determined by randomization. The nature of the second night with the device, will be the reverse of the first, in a crossover fashion.
OTHER
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Memowave emitting sound
Patients worn Memowave during one night, and the device emits sounds to increase slow brain signals
Memowave emitting sounds
Memowave is worn during one night and emits sounds to increase slow brain waves
Memowave not emitting sound
Patients worn Memowave during one night, and the device doesn't emit sounds
Memowave not emitting sounds
Memowave is worn during one night and doesn't emit sounds
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Memowave emitting sounds
Memowave is worn during one night and emits sounds to increase slow brain waves
Memowave not emitting sounds
Memowave is worn during one night and doesn't emit sounds
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* At least 7 years of schooling
Exclusion Criteria
* Known neurological pathology
* High risk of apnea syndrome defined by at least 2 positive categories (each with a score ≥2) on the Berlin Questionnaire for Apnea Syndrome Screening
* High risk of behavioral disorder in REM sleep defined by an RBDSQ score\> 5.
* Taking sleeping pills or antidepressants
* Severe heart disease or unbalanced diabetes
40 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
BioSerenity
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
ICM
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-A01806-33
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.